KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Exact Sciences (EXAS) Accumulated Depreciation & Amortization (2016 - 2025)

Exact Sciences (EXAS) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $604.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 18.79% to $604.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $604.1 million through Dec 2025, up 18.79% year-over-year, with the annual reading at $604.1 million for FY2025, 18.79% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $604.1 million at Exact Sciences, up from $576.6 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $604.1 million in Q4 2025, with the low at $20.5 million in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $344.5 million, with a median of $374.3 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization increased 12.12% in 2022, then surged 1353.32% in 2023.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $214.8 million in 2021, then surged by 43.19% to $307.6 million in 2022, then surged by 35.64% to $417.2 million in 2023, then grew by 21.9% to $508.6 million in 2024, then rose by 18.79% to $604.1 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $604.1 million, $576.6 million, and $557.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.